Please use this identifier to cite or link to this item: http://dulieuso.hmu.edu.vn/handle/hmu/4474
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorNguyễn Văn, Thi-
dc.contributor.advisorĐoàn Tiến, Lưu-
dc.contributor.authorNguyễn Thị, Hảo-
dc.date.accessioned2023-11-14T04:30:43Z-
dc.date.available2023-11-14T04:30:43Z-
dc.date.issued2023-
dc.identifier.urihttp://dulieuso.hmu.edu.vn/handle/hmu/4474-
dc.description.abstractThis is a retrospective study which aims to describe invasive breast cancer images on mammograms and analyse the relationship between mammographic features and molecular breast cancer subtypes. 364 patients who met the inclusive criteria with 367 breast cancer lesions were admitted to the K hospital from January 2022 to August 2022. We found the most prevalent molecular breast cancer subtype was luminal B, the median age was 52 years old (IQR: 42 - 61), and the median tumor size was 23mm (IQR: 18-30). Overall, the most frequent mammography finding was a mass without calcification (63.7%). Irregular masses (86.6%) with indistinct margins (47.8%) were the most common mass characteristics. Within calcification findings, the fine pleomorphic morphology and grouped distribution were the most common characteristics. The irregular shape and spiculated margin of masses were related to a high rate in luminal subtypes. These characteristics increased the chance of luminal subtypes with OR = 5.7 (95%CI: 2.90 - 11.21) and OR = 3.76 (95%CI: 1.84 - 7.66), respectively. Oval/round shape and circumscribed/obscured margins of masses were related to high in triple-negative subtypes, p < 0.001. These characteristics predicted a higher chance of triple-negative (OR = 8.41 & OR = 9.95, respectively). Mass with calcification and calcification only were more common in the HER2-enriched subtype than other subtypes, p = 0.002. The fine linear or branching calcification and segmental distribution were more common in the HER2-enriched subtype than in others (25.9% vs 10.3%, respectively). The gross features with calcification inside increased the chance of HER2-enriched subtype (OR = 3.88 in calcification only and OR = 1.59 in mass with calcification, in gross feature).vi_VN
dc.description.tableofcontentsACKNOWLEDGEMENT i DECLARATION ii TABLE OF CONTENT iii ABBREVIATION vi LIST OF TABLES vii INTRODUCTION 1 CHAPTER 1. LITERATURE REVIEW 3 1.1 Epidemiology of breast disease and breast neoplasm 3 1.2. Breast anatomy 3 1.2.1. Regional lymph node and lymphatic drainage 4 1.2.2. Vessel and innervation 4 1.3. Pathology characteristic of breast gland 8 1.4. Signs and symptoms of breast lesion and tumor 9 1.5. Methods to pathology diagnosis 10 1.5.1. Fine needle aspiration 10 1.5.2. Core needle biopsy 11 1.5.3. Vacuum-assisted breast biopsy 11 1.5.4. Surgical biopsy 12 1.6. Radiology technique in breast imaging 13 1.6.1. 2D Breast ultrasound 13 1.6.2. Doppler breast ultrasound 13 1.6.3. Elastography ultrasound 14 1.6.4. Breast MRI 14 1.6.5. Breast Computer Topography 14 1.6.6. Mammography 14 1.6.7. Digital breast tomosynthesis 26 1.6.8. Contrast-enhanced mammography 26 1.7. Pathology of breast cancer 27 1.7.1. Ductal carcinoma in situ 27 1.7.2. Invasive breast cancer 27 1.7.3. Immunohistochemistry indication 29 1.7.4. Molecular biomarkers and breast cancer subtypes 31 1.8. Breast imaging features in molecular breast cancer subtypes 35 1.8.1. Study in other countries 35 1.8.2. Study in Vietnam 36 CHAPTER 2. METHODS 37 2.1. Study design and participants 37 2.2. Technique 38 2.3. Data collection 38 2.4. Data variables 38 2.4.1. Demographic information 39 2.4.2. Pathology information 39 2.4.3. Mammographic information 40 2.5. Statistical analysis 41 CHAPTER 3. RESULTS 43 3.1. Common characteristics of the study population 43 3.1.1. Prevalence of molecular breast cancer subtypes 43 3.1.2. Demographics of the study population by MBCS 44 3.1.3. Histopathological characteristics of MBCS 45 3.2. Mammographic features in invasive breast cancer 46 3.2.1. Mammographic features in IBC with NOS and other IBC 46 3.2.2. Mammographic features in molecular breast cancer subtypes 49 3.2.3. Mammographic features in ER/PR positive tumors and ER&PR negative tumors 51 3.2.4. Mammographic features in triple-negative tumors and non-triple-negative tumors 54 3.2.5. Mammographic features in HER2-enriched tumors and non-HER2-enriched tumors 58 3.3. Relationship of mammographic features and molecular breast cancer subtypes 59 3.3.1. Relationship of mammographic features between ER/PR positive tumors and ER/PR negative tumors 59 3.3.2. Relationship of mammographic features between triple negative tumors and non-triple-negative tumors 61 3.3.3. Relationship of mammographic features between HER2 - enriched tumors and non HER2- enriched tumors 62 CHAPTER 4. DISCUSSION 66 4.1. Common characteristics of the study population 66 4.2. Mammographic features in invasive breast cancer 68 4.2.1. Mammographic features in invasive breast cancer types 68 4.2.2. Mammographic features in molecular breast cancer subtypes 68 4.3. Relationship of mammographic features and molecular breast cancer subtypes 69 4.3.1. Relationship of mammographic features and luminal subtypes 69 4.3.2. Relationship of mammographic features and TN subtype 71 4.3.3. Relationship of mammographic features and HER2 enriched subtype and positive HER2 expression 74 CONCLUSION 77 REFERENCES APPENDIX I. DATA COLLECTION FORMvi_VN
dc.language.isoen_USvi_VN
dc.subjectbreast cancer, mammography, molecular breast cancer subtypevi_VN
dc.titleThe relationship of mammographic features and molecular breast cancer subtypesvi_VN
dc.title.alternativeMối liên quan giữa đặc điểm hình ảnh Xquang tuyến vú và các típ phân tử ung thư vúvi_VN
dc.typeThesisvi_VN
Appears in Collections:Luận văn bác sĩ nội trú

Files in This Item:
File Description SizeFormat 
Nguyễn Thị Hảo-BSNT-CĐHA-2021-2024.docx
  Restricted Access
95.66 MBMicrosoft Word XML
Nguyễn Thị Hảo-BSNT-CĐHA-2021-2024.pdf
  Restricted Access
2.94 MBAdobe PDFbook.png
 Sign in to read


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.